Results 211 to 220 of about 33,093 (301)

Soft multiclass feature augmented deep learning to predict tumor origins using cytology or histology whole slide images. [PDF]

NPJ Digit Med
Wang CW, Lai PJ, Chu TC, Wu TK, Liang CH, Chao TK.   +5 more
europepmc   +1 more source

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Anti‐PD‐1 response has been associated with higher PD‐1 ligand (PD‐L1) expression levels in different cancer types. Cemiplimab, an anti‐PD‐1 antibody, has been shown to induce a response rate of 31% and 22% in patients with locally advanced basal cell carcinoma (BCC) and metastatic BCC respectively, who have progressed or are ...
Isabella Dommann, Gaetana Restivo, Isabel Kolm, Federica Sella, Patrick Turko, Phil F. Cheng, Mitchell Levesque, Corina Dommann‐Scherrer, Reinhard Dummer, Egle Ramelyte   +9 more
wiley   +1 more source

Application and Impact of Quality Assurance Dashboards in Cytology Laboratories—The CytoLog Application

Cytopathology, EarlyView.
The study introduces the CytoLog performance dashboard application for cytology laboratories featuring selected key performance indicators for management and staff. The application is adaptable to various laboratory settings, enhances engagement and interaction with quality, promotes self‐directed quality improvement, and helps mitigate potential bias ...
István Kovács, Péter Tamás Gesztelyi, Sándor Fiák, Tamás Székely, Szabolcs Takács, Ilona Kovács, Gábor Méhes, Balázs Járay   +7 more
wiley   +1 more source

A study of Pap smear abnormalities in asymptomatic women attending a tertiary care hospital. [PDF]

Bioinformation
Raghuwanshi NS, Jana D, Agrawal A, Nema P, Gupta VK.   +4 more
europepmc   +1 more source

When Small Cells Matter: Diagnosing Bladder Small Cell Carcinoma on Urine Cytology

Cytopathology, EarlyView.
Small cell carcinoma of the bladder is rare, aggressive and diagnostically challenging on urine cytology. We report a case detected in urine and confirmed by cell block immunohistochemistry, highlighting the importance of careful assessment and limitations of the Paris System.
Haley Corbin, Samer Khader, Gabriela Quiroga‐Garza, Liron Pantanowitz   +3 more
wiley   +1 more source

Can cytology accurately predict the malignancy of feline mammary gland tumours? [PDF]

Vet Evid
Virtanen J.
europepmc   +1 more source

A Unified Deep Learning Framework for Instance Segmentation Across Diverse Cytological Stains

Cytopathology, EarlyView.
Transformer‐based unified cytology segmentation across Papanicolaou, Feulgen and AgNOR achieves stain‐invariant performance. Mask2Former maximises boundary precision (AP75) on the combined dataset, enabling one model to replace multiple stain‐specific deployments without accuracy loss while simplifying clinical integration.
Luís Otávio Santos, Rodrigo de Paula E. Silva Ribeiro, Bibiana Quatrin Tiellet, Laura Maria Effting Silva, Fabiana Botelho de Miranda Onofre, Alexandre Sherlley Casimiro Onofre, Aldo von Wangenheim   +6 more
wiley   +1 more source

Comprehensive evaluation of TIR 3B thyroid nodules: Clinical, Ultrasonographical and Cytological features for prediction of malignancy. [PDF]

Endocrine
Barca I, Prinzi A, Di Benedetto G, Arcidiacono F, Piticchio T, Tumino D, Evola G, Trovato MA, Bosco A, Marturano I, Pellegriti G, Malandrino P, Russo M, Frasca F.   +13 more
europepmc   +1 more source

The Impact of Change in Practicing Cytopathologists' Team on Risk of Malignancy in a Retrospective Single‐Centre Project of 652 Thyroid Nodules: A Quality Assurance Project

Cytopathology, EarlyView.
This quality assurance project confirms that thyroid FNAC is a reliable tool for assessing the risk of malignancy (ROM), with ROM rates aligning with published data. However, cytology team changes can reveal interobserver variability and shift category distribution and malignancy rates, underlining the need for ongoing quality assurance and training ...
Pauline Kuerten, Dieter Erdin, Andrea Goldmann, Bastian Jentsch, Sina Schmidt, Peter Karl Bode   +5 more
wiley   +1 more source